Gimoti Interactions
There are 364 drugs known to interact with Gimoti (metoclopramide), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 53 are major, 300 are moderate, and 11 are minor.
- View all 364 medications that may interact with Gimoti
- View Gimoti alcohol/food interactions (2)
- View Gimoti disease interactions (10)
Most frequently checked interactions
View interaction reports for Gimoti (metoclopramide) and the medicines listed below.
- amitriptyline
- armodafinil
- atorvastatin
- azathioprine
- azithromycin
- bupropion
- cetirizine
- ciprofloxacin
- cyclobenzaprine
- Dexilant (dexlansoprazole)
- Eliquis (apixaban)
- famotidine
- fluticasone nasal
- gabapentin
- hydroxyzine
- hyoscyamine
- levetiracetam
- Lexapro (escitalopram)
- Linzess (linaclotide)
- metformin
- metoprolol
- mirtazapine
- montelukast
- Norco (acetaminophen / hydrocodone)
- Nurtec ODT (rimegepant)
- omeprazole
- pantoprazole
- potassium chloride
- propranolol
- tramadol
Gimoti alcohol/food interactions
There are 2 alcohol/food interactions with Gimoti (metoclopramide).
Gimoti disease interactions
There are 10 disease interactions with Gimoti (metoclopramide) which include:
- depression
- gastrointestinal disorders
- NMS
- pheochromocytoma
- seizures
- tardive dyskinesia
- fluid retention
- hypertension
- parkinsonism
- renal dysfunction
More about Gimoti (metoclopramide)
- Gimoti consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: GI stimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.